Page 192 - Read Online
P. 192
Hirschberg et al. Neuroimmunol Neuroinflammation 2018;5:27 I http://dx.doi.org/10.20517/2347-8659.2018.31 Page 11 of 11
64. Stathopoulos A, Pretto C, Devillers L, Pierre D, Hofman FM, Epstein AL, Farghadani H, Kruse CA, Jadus MR, Chen TC, Schijns VE.
Exploring the therapeutic efficacy of glioma vaccines based on allo- and syngeneic antigens and distinct immunological co-stimulation
activators. J Clin Cell Immunol 2012;Suppl 5:004.
65. Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W, Baumgartner R. Interstitial photodynamic therapy of
nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med 2007;39:386-93.
66. Hirschberg H, Zhang MJ, Gach HM, Uzal FA, Peng Q, Sun CH, Chighvinadze D, Madsen SJ. Targeted delivery of bleomycin to the
brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J Neurooncol 2009;95:317-29.
67. Madsen SJ, Hirschberg H. Site-specific opening of the blood-brain barrier. J Biophotonics 2010;3:356-67.
68. Madsen SJ, Gach HM, Hong SJ, Uzal FA, Peng Q, Hirschberg H. Increased nanoparticle-loaded exogenous macrophage migration into
the brain following PDT-induced blood-brain barrier disruption. Lasers Surg Med 2013;45:524-32.